A Comparative Clinical Study of Hingvadi Churna and Trivritadi Taila Anuvasana Basti in the Management of Kashtartava(PAIN DURING MENSTRUATION)

A Comparative Clinical Study of Hingvadi Churna and Trivritadi Taila Anuvasana Basti in the Management of Kashtartava with special reference to Primary Dysmenorrhoea

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/11/016433

Enrollment

Registered

2018-11-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N946- Dysmenorrhea, unspecified

Interventions

Intervention1: HINGVADI CHURNA: CONTENTS-Hingu(Ferula narthex Boiss),Dry Ginger(Zingiber officinale Rosc),Maricha(Piper nigrum Linn.),Pippali(Piper longum Linn),Kustha(Saussurea lappa C.B.Clarke),Yava

Eligibility

Inclusion criteria

Inclusion criteria: 1.PATIENTS COMING WITH CHIEF COMPLAINT OF KASHTARTAVA WITH SCANTY OR AVERAGE AMOUNT OF MENSES ALONG WITH ASSOCIATED SYMPTOMS. 2.PATIENTS IN AGE GROUP OF 16 TO 30 YEARS. 3.PATIENTS WITH H/O USING ANALGESICS DURING MENSES

Exclusion criteria

Exclusion criteria: 1.THE PATIENT SUFFERING FROM MALIGNANT SYSTEMIC DISORDERS, SPECIALLY THOSE ARE MENTIONED AS ASADHYA VYADHI AS PER CLINICAL TEXT OF AYURVEDA WILL BE EXCLUDED. 2.SUBJECTS HAVING ORGANIC PATHOLOGY OF UTERUS AND ADNEXA EG.-FIBROID UTERUS, CARCINOMA OF ENDOMETRIUM ETC.

Design outcomes

Secondary

Measure	Time frame
Relief form kashtartavaTimepoint: 2 months	—

Primary

Measure	Time frame
Improvement in symptoms of kashtartavaTimepoint: Improvement in symptoms of kashtartava in 2 months	—

Countries

India

Contacts

Public ContactDR B PUSHPALATHA

NATIONAL INSTITUTE OF AYURVEDA, JAIPUR

PUSHPALATHANIA@GMAIL.COM9413206790

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026